Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer.

Clinical trial NCT01692262 · COMPLETED

Trial details

NCT number: NCT01692262
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Castrate-Resistant Prostate Cancer (mCRPC),Efficacy,Safety and Tolerability,Pharmacokinetics,Pharmacodynamics,Tumour Response.

Start date: 2012-11-01
Primary completion: 2014-06-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.